PMID-sentid Pub_year Sent_text compound_name comp_offset prot_official_name organism prot_offset 25439907-2 2015 In this study, cellulose/Mn3O4 composites were successfully fabricated using four types of alkalis (urea (CO(NH2)2), hexamethylenetetramine ((CH2)6N4, HMT), NaOH, and KOH) by an environmentally-friendly sonochemistry method. manganese oxide 25-30 histamine N-methyltransferase Homo sapiens 151-154 26039669-0 2015 Surface Mn(II) oxidation actuated by a multicopper oxidase in a soil bacterium leads to the formation of manganese oxide minerals. manganese oxide 105-120 Multicopper oxidase Escherichia coli 39-58 24919932-2 2014 METHODS: Manganese oxide nanoparticles (Mn3O4 NPs) were synthesized and modified with LHRH targeting peptide or anti-melanoma antibodies (cancer targeting moieties) and a MMP2 cleavable peptide (a possible chemotactic factor). manganese oxide 9-24 gonadotropin releasing hormone 1 Mus musculus 86-90 24919932-2 2014 METHODS: Manganese oxide nanoparticles (Mn3O4 NPs) were synthesized and modified with LHRH targeting peptide or anti-melanoma antibodies (cancer targeting moieties) and a MMP2 cleavable peptide (a possible chemotactic factor). manganese oxide 9-24 matrix metallopeptidase 2 Mus musculus 171-175 24919932-2 2014 METHODS: Manganese oxide nanoparticles (Mn3O4 NPs) were synthesized and modified with LHRH targeting peptide or anti-melanoma antibodies (cancer targeting moieties) and a MMP2 cleavable peptide (a possible chemotactic factor). manganese oxide 40-45 gonadotropin releasing hormone 1 Mus musculus 86-90 24919932-2 2014 METHODS: Manganese oxide nanoparticles (Mn3O4 NPs) were synthesized and modified with LHRH targeting peptide or anti-melanoma antibodies (cancer targeting moieties) and a MMP2 cleavable peptide (a possible chemotactic factor). manganese oxide 40-45 matrix metallopeptidase 2 Mus musculus 171-175 24615799-5 2014 Electrochemical impedance spectroscopy analysis provides strong evidence for the enhancement of the electrical conductivity of 2 D nanostructured manganese oxide upon Ru substitution, which is mainly responsible for the excellent electrode performance of Li-Mn1-x Rux O2 nanocomposites. manganese oxide 146-161 MN1 proto-oncogene, transcriptional regulator Homo sapiens 258-261 24971574-4 2014 The synthesized mesoporous manganese oxides demonstrated enhanced redox (H2-TPR) and catalytic performances (CO oxidation) compared to nonporous analogues. manganese oxide 27-43 translocated promoter region, nuclear basket protein Homo sapiens 76-79 24799179-9 2014 When PhCH2C(CH3)2OOH (MPPH) is used as oxidant for the oxidation of c-C6H12, the major products are c-C6H11OH, c-C6H10O, and PhCH2C(CH3)2OH (MPPOH), suggesting heterolytic cleavage of MPPH to generate a Mn O intermediate. manganese oxide 203-207 phosphoinositide-3-kinase regulatory subunit 2 Homo sapiens 22-26 24799179-9 2014 When PhCH2C(CH3)2OOH (MPPH) is used as oxidant for the oxidation of c-C6H12, the major products are c-C6H11OH, c-C6H10O, and PhCH2C(CH3)2OH (MPPOH), suggesting heterolytic cleavage of MPPH to generate a Mn O intermediate. manganese oxide 203-207 phosphoinositide-3-kinase regulatory subunit 2 Homo sapiens 184-188 20867060-1 2010 A new minimal model is constructed for the doped manganese oxides which exhibit colossal magnetoresistance, involving a broad spin-majority conduction band as well as nearly localized spin-minority electron states. manganese oxide 49-65 spindlin 1 Homo sapiens 126-130 23391134-7 2013 Catalytic activities, normalized to surface area (BET), decrease in the series Mn2O3 > Mn3O4 >> lambda-MnO2, where the latter is derived from spinel LiMn2O4 following partial Li(+) removal. manganese oxide 90-95 delta/notch like EGF repeat containing Homo sapiens 50-53 23282798-6 2013 The H(2)-TPR results suggested that there was a strong interaction between the manganese oxide and cerium oxide on the surface of CNTs. manganese oxide 79-94 relaxin 2 Homo sapiens 4-8 23282798-6 2013 The H(2)-TPR results suggested that there was a strong interaction between the manganese oxide and cerium oxide on the surface of CNTs. manganese oxide 79-94 translocated promoter region, nuclear basket protein Homo sapiens 9-12 22363328-13 2012 In addition to Fe(III) oxides, Mtr pathway is also involved in reduction of manganese oxides and other metals. manganese oxide 76-92 tryptophan permease Shewanella oneidensis MR-1 31-34 21741139-3 2011 At pH 5.5, about 90% of BPF was oxidized in 20 min in a solution containing 100 muM MnO(2) and 4.4 muM BPF. manganese oxide 84-87 latexin Homo sapiens 80-83 21673400-6 2011 In addition spin resolved Auger electron spectra of the reference substances MnO, Mn(2)O(3) and Mn(II)(acetate)(2) 4H(2)O are given. manganese oxide 77-80 spindlin 1 Homo sapiens 12-16 20638968-1 2010 We report an in situ soft chemical synthesis of a novel hybrid material, cellulose-nanoscale-manganese oxide composite (C-NMOC), and its application for Pb(II) removal from aqueous solutions. manganese oxide 93-108 submaxillary gland androgen regulated protein 3B Homo sapiens 153-159 20638968-8 2010 The Pb(II) adsorption capacity of C-NMOC (per gram of Mn present) was several times higher than commercial manganese oxide (beta-MnO2) and at least twice larger than NMO. manganese oxide 107-122 submaxillary gland androgen regulated protein 3B Homo sapiens 4-10 23970370-2 2013 The Mn3O4 nanoparticles were characterized by XRD, ATR-FTIR, TEM, Raman, UV/VIS and magnetometry techniques. manganese oxide 4-9 ATR serine/threonine kinase Homo sapiens 51-54 23970370-4 2013 The complete conversion of the precursor to Mn3O4 nanoparticles occurred after 96 h at 180 C for the reaction performed in BMI NTf2. manganese oxide 44-49 nuclear transport factor 2 Homo sapiens 128-132 23970370-6 2013 Magnetometry revealed that Mn3O4 nanoparticles synthesized in either oleylamine or BMI NTf2 exhibited ferrimagnetic behavior at low temperatures, whereas they were paramagnetic at room temperature. manganese oxide 27-32 nuclear transport factor 2 Homo sapiens 87-91 23168564-1 2013 In this study, we have shown the feasibility of hollow manganese oxide nanoparticles (HMON) conjugated with an antibody of Abeta1-40 peptide (abAbeta40) (HMON-abAbeta40) for MRI of amyloid plaques in APP/PS1 transgenic mice. manganese oxide 55-70 presenilin 1 Mus musculus 204-207 20929249-4 2010 The MnO nanoparticle was nearly paramagnetic down to T=3 K. The MnO nanocolloid showed a high longitudinal water proton relaxivity of r1=7.02 s(-1) mM(-1) with the r2/r1 ratio of 6.83 due to five unpaired S-state electrons of Mn(II) ion (S=5/2) as well as a high surface to volume ratio of the MnO nanoparticle. manganese oxide 4-7 CD1e molecule Homo sapiens 164-183 20929249-4 2010 The MnO nanoparticle was nearly paramagnetic down to T=3 K. The MnO nanocolloid showed a high longitudinal water proton relaxivity of r1=7.02 s(-1) mM(-1) with the r2/r1 ratio of 6.83 due to five unpaired S-state electrons of Mn(II) ion (S=5/2) as well as a high surface to volume ratio of the MnO nanoparticle. manganese oxide 64-67 CD1e molecule Homo sapiens 164-183 20929249-4 2010 The MnO nanoparticle was nearly paramagnetic down to T=3 K. The MnO nanocolloid showed a high longitudinal water proton relaxivity of r1=7.02 s(-1) mM(-1) with the r2/r1 ratio of 6.83 due to five unpaired S-state electrons of Mn(II) ion (S=5/2) as well as a high surface to volume ratio of the MnO nanoparticle. manganese oxide 64-67 CD1e molecule Homo sapiens 164-183 20638968-0 2010 A novel cellulose-manganese oxide hybrid material by in situ soft chemical synthesis and its application for the removal of Pb(II) from water. manganese oxide 18-33 submaxillary gland androgen regulated protein 3B Homo sapiens 124-130 20867060-1 2010 A new minimal model is constructed for the doped manganese oxides which exhibit colossal magnetoresistance, involving a broad spin-majority conduction band as well as nearly localized spin-minority electron states. manganese oxide 49-65 spindlin 1 Homo sapiens 184-188 16584268-1 2006 Multilayered manganese oxide nanocomposites intercalated with strong (poly(diallyldimethylammonium) chloride, PDDA) and weak (poly(allylamine hydrochloride), PAH) polyelectrolytes can be produced on polycrystalline platinum electrode in a thin film form by a simple, one-step electrochemical route. manganese oxide 13-28 phenylalanine hydroxylase Homo sapiens 158-161 20499830-4 2010 Association of MnO and ZnO to three model biomedically important proteins (albumin, protamine and thrombin) has been characterized by ultra-violet and dynamic laser light spectroscopy, UVS and DLLS respectively. manganese oxide 15-18 coagulation factor II, thrombin Homo sapiens 98-106 19560334-6 2009 The suppression of CH(4) production rates as well as total seasonal CH(4) flux could be due to the increased concentrations of active iron, free iron, manganese oxides, and sulfate in the amended soil, which acted as electron acceptors and controlled methanogens" activity by limiting substrates availability. manganese oxide 151-167 COP9 signalosome subunit 4 Drosophila melanogaster 19-24 17188703-5 2007 SiO(2)-TiO(2) pillared layered manganese oxide nanohybrid had a BET surface area of 98 m(2)/g with a gallery height of about 1.43 nm between layers. manganese oxide 31-46 delta/notch like EGF repeat containing Homo sapiens 64-67 17321673-4 2007 Thermal and textural characterization of manganese oxide doped titania materials were characterized by X-ray diffraction (XRD), thermogravemetry (TG), BET and TEM-EDAX studies. manganese oxide 41-56 delta/notch like EGF repeat containing Homo sapiens 151-154 17321673-4 2007 Thermal and textural characterization of manganese oxide doped titania materials were characterized by X-ray diffraction (XRD), thermogravemetry (TG), BET and TEM-EDAX studies. manganese oxide 41-56 MFT2 Homo sapiens 159-162 16584268-5 2006 The interlayer PAH contains neutral (-NH2) and positively charged (-NH3(+)) amine groups, and the -NH3(+) groups are associated with Cl- (to generate -NH3(+) Cl- ion pairs) as well as the negatively charged manganese oxide layers. manganese oxide 207-222 phenylalanine hydroxylase Homo sapiens 15-18 16584268-9 2006 X-ray photoelectron spectroscopy revealed that, in this case, excess negative charges generated on the manganese oxide layers upon reduction can be balanced by the protons being released from the -NH3(+) Cl- sites in the interlayer PAH; the Cl- anions becoming unnecessary are inevitably excluded from the interlayer, and vice versa upon oxidation. manganese oxide 103-118 phenylalanine hydroxylase Homo sapiens 232-235 11775144-12 2001 XANES spectral analysis indicated that most Co(II) was oxidized to Co(III) and probably incorporated structurally into manganese oxides. manganese oxide 119-135 mitochondrially encoded cytochrome c oxidase II Homo sapiens 44-50 15509014-0 2004 Sorption of Co(II), Ni(II), and Zn(II) on biogenic manganese oxides produced by a Mn-oxidizing fungus, strain KR21-2. manganese oxide 51-67 mitochondrially encoded cytochrome c oxidase II Homo sapiens 12-18 15707057-0 2005 Mechanisms of Pb(II) sorption on a biogenic manganese oxide. manganese oxide 44-59 submaxillary gland androgen regulated protein 3B Homo sapiens 14-20 15707057-1 2005 Macroscopic Pb(II) uptake experiments and Pb L3-edge extended X-ray absorption fine structure (EXAFS) spectroscopy were combined to examine the mechanisms of Pb(II) sequestration by a biogenic manganese oxide and its synthetic analogues, all of which are layer-type manganese oxides (phyllomanganates). manganese oxide 193-208 submaxillary gland androgen regulated protein 3B Homo sapiens 158-164 15500343-1 2004 The mixed-valence double salt K(3)(MnO(4))(2) crystallizes in space group P2(1)/m with Z = 2. manganese oxide 35-38 cyclin dependent kinase inhibitor 1A Homo sapiens 74-79 15482439-9 2004 The cell surface exposure of OmcA could allow it to directly transfer electrons to extracellular electron acceptors (e.g. manganese oxides) and is consistent with its in vivo role. manganese oxide 122-138 OmcA/MtrC family decaheme c-type cytochrome Shewanella oneidensis MR-1 29-33 34958560-2 2021 Herein, we explored and simply synthesized a biomimic and translational Mn3O4 nanoenzyme (HSA-Mn3O4) to constrain ischemic stroke reperfusion-induced nervous system injury. manganese oxide 72-77 albumin Homo sapiens 90-93 11688686-5 2001 The results showed that redox processes with nitrate, manganese oxide and ferric iron as the electron acceptors exhibited hydrogen threshold values close to PCE/TCE dechlorination, whereas cis-DCE and VC dechlorinations exhibited hydrogen threshold values in the range of sulfate reduction and methanogenesis, respectively. manganese oxide 54-69 24-dehydrocholesterol reductase Homo sapiens 193-196 8515258-5 1993 We have shown that the manganese present in serum after exposure to manganese oxide is bound to transferrin as trivalent manganic ion. manganese oxide 68-83 transferrin Homo sapiens 96-107 34958560-5 2021 Furthermore, HSA-Mn3O4 effectively releases Mn ions and promotes the increase of superoxide dismutase 2 activity. manganese oxide 17-22 albumin Homo sapiens 13-16 34757347-2 2021 Here, we spun nanoparticles of nickel-manganese oxides along with carbon nanotubes into carbon nanofibers and engineered a 3D networked Ni-Mn oxides/CNT@CNF free-standing membrane for flexible supercapacitor applications. manganese oxide 38-54 NPHS1 adhesion molecule, nephrin Homo sapiens 153-156 34601811-7 2021 Furthermore, the oxygen scavenging effect created by Mn3 O4 nanorods was successfully applied to a mouse model of PD; the amount of alpha-synuclein (alpha-syn) in the cerebrospinal fluid of PD mice was reduced by 61.2% in two weeks, thus demonstrating the potential application of facet-directed Mn3 O4 NPs for the clinical therapy of neurodegenerative disease. manganese oxide 53-59 synuclein, alpha Mus musculus 132-147 34601811-7 2021 Furthermore, the oxygen scavenging effect created by Mn3 O4 nanorods was successfully applied to a mouse model of PD; the amount of alpha-synuclein (alpha-syn) in the cerebrospinal fluid of PD mice was reduced by 61.2% in two weeks, thus demonstrating the potential application of facet-directed Mn3 O4 NPs for the clinical therapy of neurodegenerative disease. manganese oxide 53-59 synuclein, alpha Mus musculus 149-158 34601811-7 2021 Furthermore, the oxygen scavenging effect created by Mn3 O4 nanorods was successfully applied to a mouse model of PD; the amount of alpha-synuclein (alpha-syn) in the cerebrospinal fluid of PD mice was reduced by 61.2% in two weeks, thus demonstrating the potential application of facet-directed Mn3 O4 NPs for the clinical therapy of neurodegenerative disease. manganese oxide 296-302 synuclein, alpha Mus musculus 149-158 34890821-0 2022 Inulin Coated Mn3O4 Nanocuboids Coupled with RNA Interference Reverse Intestinal Tumorigenesis in Apc Knockout Murine Colon Cancer Models. manganese oxide 14-19 APC, WNT signaling pathway regulator Mus musculus 98-101 34567850-0 2021 Mineral Manganese Oxides as Oxidation Catalysts: Capabilities in the CO-PROX Reaction. manganese oxide 8-24 pyruvate dehydrogenase complex component X Homo sapiens 72-76 35367227-0 2022 Highly efficient surface sequestration of Pb2+ and Cr3+ from water using a Mn3O4 anchored reduced graphene oxide: Selective removal of Pb2+ from real water. manganese oxide 75-80 teratocarcinoma-derived growth factor 1 pseudogene 3 Homo sapiens 51-54 35367227-4 2022 The prepared rGO-Mn3O4 had significant adsorption efficiencies for Pb2+ and Cr3+, achieving maximum sequestration capacities of 130.28 and 138.51 mg g-1 for Pb2+ and Cr3+, respectively, according to the Langmuir model. manganese oxide 17-22 teratocarcinoma-derived growth factor 1 pseudogene 3 Homo sapiens 76-79 35367227-4 2022 The prepared rGO-Mn3O4 had significant adsorption efficiencies for Pb2+ and Cr3+, achieving maximum sequestration capacities of 130.28 and 138.51 mg g-1 for Pb2+ and Cr3+, respectively, according to the Langmuir model. manganese oxide 17-22 teratocarcinoma-derived growth factor 1 pseudogene 3 Homo sapiens 166-169 35579617-7 2022 Additionally, manganese oxide nanoparticles (MnOx) modified with Ab2 can further quench the ECL signal of Ru@DMSNs via the RET between Ru@DMSNs and MnOx. manganese oxide 14-29 ret proto-oncogene Homo sapiens 123-126 35485407-2 2022 Here, bovine serum albumin-modified Mn3O4 nanoparticles (BSA-Mn3O4 NPs) with good biocompatibility were synthesized by a one-step biomineralization method using BSA as a template. manganese oxide 36-41 albumin Homo sapiens 13-26 35606848-3 2022 RESULTS: In this article, a self-enhanced Mn3O4 nanoplatform (MPG NPs) was established, which can react with glutathione to produce Mn2+ to enhance T1-weighted magnetic resonance imaging (MRI) and mediate in vivo real-time MDR monitoring. manganese oxide 42-47 N-methylpurine DNA glycosylase Homo sapiens 62-65 35485407-2 2022 Here, bovine serum albumin-modified Mn3O4 nanoparticles (BSA-Mn3O4 NPs) with good biocompatibility were synthesized by a one-step biomineralization method using BSA as a template. manganese oxide 61-66 albumin Homo sapiens 13-26 35477452-5 2022 RESULTS: We developed a longer-circulating, inflammation-sensing, ROS-scavenging versatile nanoplatform by stably loading catalase-mimicking 1-dodecanethiol stabilized Mn3O4 (dMn3O4) nanoparticles inside ROS-sensitive nanomicelles (PTC), resulting in an ROS-sensitive nanozyme (PTC-M). manganese oxide 168-173 catalase Mus musculus 122-130 33861233-3 2021 The electrochemical performance of the Mn3O4/CeO2 nanocomposite modified glassy carbon electrode (Mn3O4/CeO2/GCE) was investigated. manganese oxide 39-44 guanylate cyclase 2E, pseudogene Homo sapiens 109-112 34998142-2 2022 Here, transferrin (Trf)-directed manganese oxide with 3D nanomorphology was developed. manganese oxide 33-48 transferrin Homo sapiens 6-17 34998142-2 2022 Here, transferrin (Trf)-directed manganese oxide with 3D nanomorphology was developed. manganese oxide 33-48 transferrin Homo sapiens 19-22 34998142-4 2022 Fortunately, not only was the controllable structure discovered, but Trf-Mn3O4 NCs also showed tetra-enzyme mimic activities involving peroxidase-, ascorbic acid oxidase-, catalase- and superoxide dismutase-mimic activities. manganese oxide 73-78 transferrin Homo sapiens 69-72 34998142-5 2022 Further, the catalytic properties and steady-state kinetic of Trf-Mn3O4 NCs was explored, systematically. manganese oxide 66-71 transferrin Homo sapiens 62-65 34998142-6 2022 Moreover, we develop simple colorimetric sensor based on the peroxidase-mimic activity of Trf-Mn3O4 NCs for the detection of gallic acid (GA) with the linear range within 0.1-40 muMu, and the limit of detection was 41.2 nM (S/N = 3). manganese oxide 94-99 transferrin Homo sapiens 90-93 33861233-5 2021 Moreover, Mn3O4/CeO2/GCE exhibited excellent reproducibility, repeatability, and long-term storage stability. manganese oxide 10-15 guanylate cyclase 2E, pseudogene Homo sapiens 21-24 32656947-4 2020 In galvanostatic mode, the lithiation of Mn3 O4 undergoes multi-step phase transitions following a reaction pathway of Mn3 O4 + Li+ LiMn3 O4 + Li+ MnO + Li2 O Mn + Li2 O. manganese oxide 41-47 ATP binding cassette subfamily A member 12 Homo sapiens 157-160 33591771-1 2021 Manganese oxides composed of various valence states Mnx+ (x = 2, 3, and 4) have attracted wide attention as promising electrode materials for asymmetric supercapacitor. manganese oxide 0-16 keratin 86 Homo sapiens 52-55 33591771-1 2021 Manganese oxides composed of various valence states Mnx+ (x = 2, 3, and 4) have attracted wide attention as promising electrode materials for asymmetric supercapacitor. manganese oxide 0-16 xenotropic and polytropic retrovirus receptor 1 Homo sapiens 58-73 33591771-3 2021 Appropriate regulation content of Mnx+ in mixed-valent manganese oxide can tune the electronic structure and further improve their conductivity and performance. manganese oxide 55-70 keratin 86 Homo sapiens 34-37 32768735-2 2021 In the paper, Mn3O4-Fe3O4@C hybrids with different architectures were synthesized by incubation of electrospun FeOx-containing carbon fiber (Fe-CNF) in KMnO4 solution followed by annealing. manganese oxide 14-19 NPHS1 adhesion molecule, nephrin Homo sapiens 144-147 33320703-10 2020 Finally, Mn3O4 NPs mediated SGs formation via the phosphorylation of eIF2alpha. manganese oxide 9-14 eukaryotic translation initiation factor 2A Homo sapiens 69-78 32656947-4 2020 In galvanostatic mode, the lithiation of Mn3 O4 undergoes multi-step phase transitions following a reaction pathway of Mn3 O4 + Li+ LiMn3 O4 + Li+ MnO + Li2 O Mn + Li2 O. manganese oxide 41-47 ATP binding cassette subfamily A member 12 Homo sapiens 170-173 32656947-6 2020 These results are in sharp contrast to that obtained under a constant-voltage discharge mode, where only a single-step lithiation process of Mn3 O4 + Li+ Mn + Li2 O is observed. manganese oxide 141-147 ATP binding cassette subfamily A member 12 Homo sapiens 161-164 32250753-0 2020 Nano-manganese oxide-functionalized-oleyl amine as a simple and low cost nanosorbent for remediation of ZnII/CoII and their radioactive nuclides 65Zn and 60Co from water. manganese oxide 5-20 mitochondrially encoded cytochrome c oxidase II Homo sapiens 109-113 31909642-0 2020 Repeated administrations of Mn3O4 nanoparticles cause testis damage and fertility decrease through PPAR-signaling pathway. manganese oxide 28-33 peroxisome proliferator activated receptor alpha Homo sapiens 99-103 31935871-7 2020 NPs of manganese (Mn and Mn3O4) induced the most remarkable ToxTracker response with activation of reporters for oxidative stress, DNA damage, protein unfolding and p53-related stress. manganese oxide 25-30 tumor protein p53 Homo sapiens 165-168 31740235-9 2020 In PC12 cells, the decrease of DA content was mainly due to the downregulation of DOPA decarboxylase (DDC) expression caused by Mn3O4 NPs treatment. manganese oxide 128-133 dopa decarboxylase Rattus norvegicus 82-100 32048696-0 2020 Structures of mixed manganese ruthenium oxides (Mn1-xRux)O2 crystallised under acidic hydrothermal conditions. manganese oxide 20-46 MN1 proto-oncogene, transcriptional regulator Homo sapiens 48-51 31731188-0 2020 PSA targeted dual-modality manganese oxide-mesoporous silica nanoparticles for prostate cancer imaging. manganese oxide 27-42 kallikrein B, plasma 1 Mus musculus 0-3 31731188-2 2020 The aim of the present study was to design and evaluate the value of prostate-specific membrane antigen (PSA)-targeted manganese oxide-mesoporous silica nanoparticles (Mn-Msns) for the detection of prostate cancer. manganese oxide 119-134 kallikrein B, plasma 1 Mus musculus 69-103 31731188-2 2020 The aim of the present study was to design and evaluate the value of prostate-specific membrane antigen (PSA)-targeted manganese oxide-mesoporous silica nanoparticles (Mn-Msns) for the detection of prostate cancer. manganese oxide 119-134 kallikrein B, plasma 1 Mus musculus 105-108 30801922-1 2019 We report reversible electrochemical insertion of NO3 - into manganese(II, III) oxide (Mn3 O4 ) as a cathode for aqueous dual-ion batteries. manganese oxide 61-85 NBL1, DAN family BMP antagonist Homo sapiens 50-53 31534553-0 2019 Biomineralization-inspired Crystallization of Manganese Oxide on Silk Fibroin Nanoparticles for in vivo MR/fluorescence Imaging-assisted Tri-modal Therapy of Cancer. manganese oxide 46-61 tRNA-Ile (anticodon AAT) 9-1 Homo sapiens 137-140 31642665-1 2019 A new three-dimensional metal-organic framework (MOF) was synthesized by linking ditopic amino functionalized polyoxometalate [N(C4H9)4]3[MnMo6O18{(OCH2)3CNH2}2] with 4-connected tetrahedral tetrakis(4-formylphenyl)methane building units through imine condensation. manganese oxide 126-161 lysine acetyltransferase 8 Homo sapiens 24-53 30801922-1 2019 We report reversible electrochemical insertion of NO3 - into manganese(II, III) oxide (Mn3 O4 ) as a cathode for aqueous dual-ion batteries. manganese oxide 87-93 NBL1, DAN family BMP antagonist Homo sapiens 50-53 30801922-3 2019 Ex situ HRTEM and corresponding EDX mapping results suggest that NO3 - insertion de-crystallizes the structure of Mn3 O4 . manganese oxide 114-120 NBL1, DAN family BMP antagonist Homo sapiens 65-68 30801922-4 2019 Kinetic studies reveal fast migration of NO3 - in the Mn3 O4 structure. manganese oxide 54-60 NBL1, DAN family BMP antagonist Homo sapiens 41-44 29605612-1 2018 Cryptomelane-type octahedral molecular sieve manganese oxide (OMS-2) possesses high redox potential and has attracted much interest in its application for oxidation arsenite (As(III)) species of arsenic to arsenate (As(V)) to decrease arsenic toxicity and promote total arsenic removal. manganese oxide 45-60 SRC proto-oncogene, non-receptor tyrosine kinase Homo sapiens 216-221 29267135-6 2019 An investigation of the mechanism demonstrated that the enhancement effect could be attributed to the introduction of the manganese oxide nanoparticles, which could promote the utilization of O3 and/or enhance the formation of free radicals ( OH, O2H and O2-) on the solid surface and further accelerate the degradation of the organic compounds present in the wastewater. manganese oxide 122-137 immunoglobulin kappa variable 1D-39 Homo sapiens 248-261 30388682-0 2019 Cd2+ adsorption performance of tunnel-structured manganese oxides driven by electrochemically controlled redox. manganese oxide 49-65 CD2 molecule Homo sapiens 0-3 30388682-5 2019 The adsorption capacity of tunnel-structured manganese oxides for Cd2+ was remarkably enhanced by electrochemical redox reactions. manganese oxide 45-61 CD2 molecule Homo sapiens 66-69 30388682-9 2019 Due to the differences in their tunnel size and supporting ion species, the tunnel-structured manganese oxides follow the order of cryptomelane (192.0 mg g-1) > todorokite (44.8 mg g-1) > pyrolusite (13.5 mg g-1) in their electrochemical adsorption capacities for Cd2+. manganese oxide 94-110 CD2 molecule Homo sapiens 270-273 30068036-5 2018 Both XRD and TEM results confirm that the manganese oxides were dispersed more uniformly on MnOx/MCM-41 than on MnOx/ZSM-5 or MnOx/13X. manganese oxide 42-58 MFT2 Homo sapiens 13-16 29697864-3 2018 Herein, a convenient route for the synthesis of Mn3 O4 nanoparticles grown in situ on hollow carbon nanofiber (denoted as HCF/Mn3 O4 ) is reported. manganese oxide 48-54 host cell factor C1 Homo sapiens 122-132 29697864-4 2018 The small size of Mn3 O4 particles combined with HCF can significantly alleviate volume changes and electrical conductivity; the strong chemical interactions between HCF and Mn3 O4 would improve the reversibility of the conversion reaction for MnO into Mn3 O4 and accelerate charge transfer. manganese oxide 18-24 host cell factor C1 Homo sapiens 166-169 29697864-4 2018 The small size of Mn3 O4 particles combined with HCF can significantly alleviate volume changes and electrical conductivity; the strong chemical interactions between HCF and Mn3 O4 would improve the reversibility of the conversion reaction for MnO into Mn3 O4 and accelerate charge transfer. manganese oxide 174-180 host cell factor C1 Homo sapiens 166-169 29697864-4 2018 The small size of Mn3 O4 particles combined with HCF can significantly alleviate volume changes and electrical conductivity; the strong chemical interactions between HCF and Mn3 O4 would improve the reversibility of the conversion reaction for MnO into Mn3 O4 and accelerate charge transfer. manganese oxide 244-247 host cell factor C1 Homo sapiens 166-169 29697864-4 2018 The small size of Mn3 O4 particles combined with HCF can significantly alleviate volume changes and electrical conductivity; the strong chemical interactions between HCF and Mn3 O4 would improve the reversibility of the conversion reaction for MnO into Mn3 O4 and accelerate charge transfer. manganese oxide 174-180 host cell factor C1 Homo sapiens 166-169 30182099-1 2018 A more reliable/eco-friendly secondary Zn-Mn battery system is built with highly active Mn3O4@carbon nanowires and near-neutral electrolytes. manganese oxide 88-93 ciliogenesis associated kinase 1 Homo sapiens 16-19 29605612-2 2018 However, coexisting ions such as As(V) and phosphate are ubiquitous and readily bond to manganese oxide surface, consequently passivating surface active sites of manganese oxide and reducing As(III) oxidation. manganese oxide 162-177 SRC proto-oncogene, non-receptor tyrosine kinase Homo sapiens 33-38 29605612-2 2018 However, coexisting ions such as As(V) and phosphate are ubiquitous and readily bond to manganese oxide surface, consequently passivating surface active sites of manganese oxide and reducing As(III) oxidation. manganese oxide 88-103 SRC proto-oncogene, non-receptor tyrosine kinase Homo sapiens 33-38 29732076-6 2018 To fill this gap, herein we demonstrated that Mn3O4 nanoparticles (NPs) possessed multiple enzyme mimicking activities (i.e., superoxide dismutase and catalase mimicking activities as well as hydroxyl radical scavenging activity). manganese oxide 46-51 catalase Mus musculus 151-159 29603822-3 2018 It is found that Mn3 O4 nanoparticles mimic the functions of all three cellular antioxidant enzymes: superoxide dismutase (SOD), catalase (CAT), and glutathione peroxidase (GPx). manganese oxide 17-23 superoxide dismutase 1 Homo sapiens 101-121 29603822-3 2018 It is found that Mn3 O4 nanoparticles mimic the functions of all three cellular antioxidant enzymes: superoxide dismutase (SOD), catalase (CAT), and glutathione peroxidase (GPx). manganese oxide 17-23 superoxide dismutase 1 Homo sapiens 123-126 29603822-3 2018 It is found that Mn3 O4 nanoparticles mimic the functions of all three cellular antioxidant enzymes: superoxide dismutase (SOD), catalase (CAT), and glutathione peroxidase (GPx). manganese oxide 17-23 catalase Homo sapiens 129-137 29603822-3 2018 It is found that Mn3 O4 nanoparticles mimic the functions of all three cellular antioxidant enzymes: superoxide dismutase (SOD), catalase (CAT), and glutathione peroxidase (GPx). manganese oxide 17-23 catalase Homo sapiens 139-142 28922532-2 2017 Herein, we report that a Mn3 O4 nanozyme functionally mimics three major antioxidant enzymes, that is, superoxide dismutase (SOD), catalase (CAT) and glutathione peroxidase (GPx) and the multienzyme activity is size as well as morphology-dependent. manganese oxide 25-31 superoxide dismutase 1 Homo sapiens 103-123 29028311-2 2017 In this study, we present tumor vasculature-targeted imaging in mice using Mn3O4 NPs through conjugation to the anti-CD105 antibody TRC105 and radionuclide copper-64 (64Cu, t1/2: 12.7 h). manganese oxide 75-80 endoglin Mus musculus 117-122 29028311-5 2017 The specificity of 64Cu-NOTA-Mn3O4@PEG-TRC105 for the vascular marker CD105 was confirmed through in vivo, in vitro, and ex vivo experiments. manganese oxide 29-34 endoglin Mus musculus 70-75 28922532-2 2017 Herein, we report that a Mn3 O4 nanozyme functionally mimics three major antioxidant enzymes, that is, superoxide dismutase (SOD), catalase (CAT) and glutathione peroxidase (GPx) and the multienzyme activity is size as well as morphology-dependent. manganese oxide 25-31 superoxide dismutase 1 Homo sapiens 125-128 28922532-2 2017 Herein, we report that a Mn3 O4 nanozyme functionally mimics three major antioxidant enzymes, that is, superoxide dismutase (SOD), catalase (CAT) and glutathione peroxidase (GPx) and the multienzyme activity is size as well as morphology-dependent. manganese oxide 25-31 catalase Homo sapiens 131-139 28922532-2 2017 Herein, we report that a Mn3 O4 nanozyme functionally mimics three major antioxidant enzymes, that is, superoxide dismutase (SOD), catalase (CAT) and glutathione peroxidase (GPx) and the multienzyme activity is size as well as morphology-dependent. manganese oxide 25-31 catalase Homo sapiens 141-144 28922532-3 2017 The redox modulatory effect of Mn3 O4 plays a crucial role in protecting the cells from MPP+ induced cytotoxicity in a Parkinson disease (PD)-like cellular model, indicating that manganese-based nanomaterials having multi-enzyme activity can robustly rescue the cells from oxidative damage and thereby possess therapeutic potential to prevent ROS-mediated neurological disorders. manganese oxide 31-37 M-phase phosphoprotein 6 Homo sapiens 88-91 28618379-2 2017 Benefitting from the distinctive nanostructure and the hybridization with well-conductive graphene, the capacity retentions of Mn3O4@G are dramatically improved from 25.5 to 58.0% after 100 cycles at 300mAg-1 and from 15.8 to 43.8% after 200 cycles at 1000mAg-1, respectively. manganese oxide 127-132 dentin matrix protein 1 Mus musculus 203-208 28618379-3 2017 Even the current rates reach up to 2000 and 3000mAg-1, Mn3O4@G electrode could still hold the highly stable capacities around 520 and 430mAhg-1, respectively. manganese oxide 55-60 dentin matrix protein 1 Mus musculus 48-53 28371370-3 2017 A rational nanostructure of hollow carbon nanoboxes filled with birnessite-type manganese oxide nanosheets (MnO2 @HCB) as a new class of molecularly-designed physical and chemical trap for lithium polysulfides (Li2 Sx (x = 4-8)) is reported. manganese oxide 80-95 ATP binding cassette subfamily A member 12 Homo sapiens 211-214 28537706-2 2017 Here we comparatively study the catalytic performance of two single-atom catalysts, Na1/HMO and Ag1/HMO (HMO = Hollandite manganese oxide), in the complete oxidation of HCHO at low temperatures, in which the products are only CO2 and H2O. manganese oxide 122-137 thioredoxin domain containing 12 Homo sapiens 84-103 28332483-2 2017 We report that [Formula: see text] serves as the electron acceptor and reacts with MnII in the presence of apoferritin to form manganese oxide cores inside the protein shell. manganese oxide 127-142 ferritin heavy chain 1 Homo sapiens 107-118 28076888-0 2017 Caspase mediated beclin-1 dependent autophagy tuning activity and apoptosis promotion by surface modified hausmannite nanoparticle. manganese oxide 106-117 beclin 1 Homo sapiens 17-25 28076888-2 2017 Here, our studies show that surface modified hausmannite nanoparticles (Mn3 O4 NPs) can uniformly cleave/splice Beclin-1 protein and alter cellular mechanism on the emphasis of tuning autophagy and subsequently promote enhancement of apoptosis. manganese oxide 45-56 beclin 1 Homo sapiens 112-120 32263743-0 2016 Intrinsic superoxide dismutase activity of MnO nanoparticles enhances the magnetic resonance imaging contrast. manganese oxide 43-46 superoxide dismutase 1 Homo sapiens 10-30 27768974-3 2017 In this study, we firstly developed ethylenediaminetetraacetic acid calcium disodium salt (EDTA)- and bovine serum albumin (BSA)-capped Mn3O4 nanoparticles (MONPs-BSA-EDTA) as a novel inorganic nanomaterials for multifunctional imaging-guided photothermal therapy, which can be degraded in a progress-controlled way by artificially introduced ascorbic acid. manganese oxide 136-141 albumin Homo sapiens 109-122 32263743-5 2016 Here we show that manganese oxide (MnO) nanoparticles (NPs) exhibit an intrinsic SOD-like activity, which is higher than that of the native Mn-dependent SOD. manganese oxide 18-33 superoxide dismutase 1 Homo sapiens 81-84 32263743-5 2016 Here we show that manganese oxide (MnO) nanoparticles (NPs) exhibit an intrinsic SOD-like activity, which is higher than that of the native Mn-dependent SOD. manganese oxide 18-33 superoxide dismutase 1 Homo sapiens 153-156 32263743-5 2016 Here we show that manganese oxide (MnO) nanoparticles (NPs) exhibit an intrinsic SOD-like activity, which is higher than that of the native Mn-dependent SOD. manganese oxide 35-38 superoxide dismutase 1 Homo sapiens 81-84 32263743-5 2016 Here we show that manganese oxide (MnO) nanoparticles (NPs) exhibit an intrinsic SOD-like activity, which is higher than that of the native Mn-dependent SOD. manganese oxide 35-38 superoxide dismutase 1 Homo sapiens 153-156 28773419-2 2016 This work reports the preparation and the physico-chemical and electrochemical characterization of spin-coated (SC) films of commercial Mn2O3, Mn3O4 and MnO2 powders. manganese oxide 143-148 spindlin 1 Homo sapiens 99-103 26530783-1 2015 Nanocrystalline biocompatible single-phase Mn-doped A-type carbonated hydroxyapatite (A-cHAp) powder has been synthesized by mechanical alloying of a stoichiometric mixture of CaCO3, CaHPO4 2H2O and MnO powder for 10 h at room temperature under open air. manganese oxide 199-202 cutA divalent cation tolerance homolog Homo sapiens 52-92 27036742-3 2015 One bacterial group in particular, Geobacter spp., can couple their respiratory metabolism to the reduction of insoluble minerals, such as iron and manganese oxides, and soluble toxic metals such as uranium. manganese oxide 148-164 histocompatibility minor 13 Homo sapiens 45-48 26184135-10 2015 Increase in nuclear p50 by m-NO-ASA was associated with translocation of p50 in to the nucleus as observed by immunoflouresence at 3 h. NO-ASA induced reactive oxygen species (ROS) as evidenced by overall increases in both H2DCFDA (2",7"-dichlorodihydrofluorescein) and DHE (dihydroethidium)-derived fluorescence. manganese oxide 27-31 nuclear factor kappa B subunit 1 Homo sapiens 20-23 26184135-10 2015 Increase in nuclear p50 by m-NO-ASA was associated with translocation of p50 in to the nucleus as observed by immunoflouresence at 3 h. NO-ASA induced reactive oxygen species (ROS) as evidenced by overall increases in both H2DCFDA (2",7"-dichlorodihydrofluorescein) and DHE (dihydroethidium)-derived fluorescence. manganese oxide 27-31 nuclear factor kappa B subunit 1 Homo sapiens 73-76 26184135-11 2015 Inhibition of ROS by N-acetyl-cysteine reversed the m-NO-ASA-mediated translocation of p50 in to the nucleus. manganese oxide 52-56 nuclear factor kappa B subunit 1 Homo sapiens 87-90